EAM Investors’s Erasca ERAS Stock Holding History

EAM Investors’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-137,925	Closed	-$2.23M	–	310
2026 Q1	$2.23M	Buy	+137,925	New	+$1.63M	0.26%	159

Other funds holding ERAS

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

EAM Investors's ERAS Position: Q2 2026 in Review

EAM Investors sold out of Erasca (ERAS) in Q2 2026, closing a stake of 137,925 shares — an estimated $2.23M sold.

EAM Investors first reported a position in ERAS in Q1 2026 and held it in 1 quarter. The position peaked at $2.23M in Q1 2026. 257 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

EAM Investors reported no remaining Erasca position as of Q2 2026 after selling out during the quarter.
EAM Investors sold 137,925 Erasca shares in Q2 2026, an estimated $2.23M.
EAM Investors first reported a position in Erasca in Q1 2026 and held it in 1 quarter.
EAM Investors's Erasca position peaked at $2.23M in Q1 2026.
257 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on EAM Investors's 13F filing for Q2 2026, filed 13 Aug 2026.